Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 15, 2022 - Issue 12
Submit an article Journal homepage
349
Views
2
CrossRef citations to date
0
Altmetric
Review

Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape

Jacopo Ulianoa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
,
Eleonora Nicolòa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyORCID Iconhttps://orcid.org/0000-0001-5042-6550
ORCID Icon,
Carla Corvajaa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;c Department of Medicine, University of Udine, Udine, ItalyORCID Iconhttps://orcid.org/0000-0002-2535-7538
ORCID Icon,
Beatrice Taurelli Salimbenia Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;d Department of Clinical and Molecular Medicine, Oncology Unit, “La Sapienza” University of RomeAzienda Ospedaliera Sant’Andrea, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-7345-4148
ORCID Icon,
Dario Trapania Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;e Department of Medical Oncology, Medical Oncology Dana Farber Cancer Institute, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0003-1672-9560
ORCID Icon &
Giuseppe Curiglianoa Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy;b Department of Oncology and Hemato-Oncology, University of Milan, Milan, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1781-2518
ORCID Icon
Pages 1399-1413 | Received 17 Jul 2022, Accepted 27 Oct 2022, Published online: 08 Nov 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rosanna Ruggiero, Raffaella Di Napoli, Nunzia Balzano, Donatella Ruggiero, Consiglia Riccardi, Antonietta Anatriello, Andrea Cantone, Liberata Sportiello, Francesco Rossi & Annalisa Capuano. (2023) Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management. Expert Review of Clinical Pharmacology 16:5, pages 423-434.
Read now

Articles from other publishers (1)

Hany E. Marei, Anwarul Hasan, Giacomo Pozzoli & Carlo Cenciarelli. (2023) Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired. Cancer Cell International 23:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.